共 33 条
[1]
Rocky Mountain Spotted Fever and Human Ehrlichiosis-United States, 1989 InfMmwr Morb Mortal Wkly Rep, 39, pp. 281-284, (1990)
[2]
Rocky Mountain spotted fever-United States, 1990, MMWR Morb Mortal Wkly Rep, 40, pp. 451-459, (1991)
[3]
Parker R.R., Rocky Mountain spotted fever: Results of fifteen years’ pro phylactic vaccination, Am J Trop Med, 21, pp. 369-383, (1941)
[4]
Kaplowitz L.G., Fischer J.J., Sparling P.F., Rocky Mountain spotted fever: A clinical dilemma, Current Clinical Topics in Infectious Diseases, 2, pp. 89-108, (1981)
[5]
Helmick C.G., Bernard K.W., D'angelo L.J., Rocky Mountain spotted fever: Clinical, laboratory, and epidemiological features of 262 cases, J Infect Dis, 150, pp. 480-488, (1984)
[6]
Wilfert C.M., Maccormack J.N., Kleeman K., Et al., Epidemiology of Rocky Mountain spotted fever as determined by active surveillance, J Infect Dis, 150, pp. 469-479, (1984)
[7]
Sexton D.J., Corey G.R., Rocky Mountain “spotless” and “almost spot less” fever: A wolf in sheep’s clothing, Clin Infect Dis, 15, pp. 439-448, (1992)
[8]
Sexton D.J., Burgdorfer W., Clinical and epidemiologic features of Rocky Mountain spotted fever in Mississippi, 1933-1973, South Med J, 68, pp. 1529-1535, (1975)
[9]
Hattwick M., O'brien R.J., Hanson B.F., Rocky Mountain spotted fever: Epidemiology of an increasing problem, Ann Intern Med, 84, pp. 732-739, (1976)
[10]
Harrell G.T., Aikawa J.K., Pathogenesis of circulatory failure in Rocky Mountain spotted fever. Alterations in the blood volume and the thiocyanate space at various stages of the disease, Arch Intern Med, 83, pp. 331-347, (1949)